Immunohematology Market Insights Video

According to Cognitive Market Research, the global Immunohematology market size was USD 2142.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 9.70% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 857.04 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 642.78 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 492.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.7% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD 107.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 42.85 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031.
• The Blood-Related Diseases held the highest Immunohematology market revenue share in 2024.